Newborn screening refers to medical tests, the majority of which are genetic, performed to identify babies with certain disorders, which without intervention, may permanently impact newborns and their families. Early recognition and treatment of most of these disorders leads to a better outcome for the newborn. The Newborn Screening Program’s goal is to help affected babies live as long and normal of a life as possible.

The Newborn Screening Program effectively identifies babies with certain disorders and is required for all newborns born in New York State unless the parents confirm, in writing, that they have a religious objection.

Quick Facts about Newborn Screening:

  • A small blood sample is collected by pricking your newborn’s heel usually 24-36 hours after birth.
  • The blood is used to screen for 50 different disorders.
  • There is no charge to you for this service.
  • Most newborns will not have one of these disorders.
  • Newborns with one of these disorders may look healthy at birth, which is why the testing must be performed to find those with a disorder. The earlier treatment is started, the better the outcome is for your newborn.
  • Screening is designed to identify all newborns with the potential for one of these disorders. Further testing is then required to verify whether or not your newborn has the disorder.

We work closely with health care providers to ensure newborns with abnormal test results receive appropriate confirmatory diagnoses and treatment.

No test is perfect. If your newborn’s healthcare provider suspects there is a problem or your newborn does not seem right despite a normal newborn screening result, your newborn may need further testing.
 

CLIA# 33D2005937 | PFI# 8523

Program Updates

Newborn Screening Program Pilot Study: Hurler Syndrome

The New York State Newborn Screening Program screens all infants born in the state for 47 different diseases. In addition, the program is currently performing a pilot study with Dr. Melissa Wasserstein (pictured left), from the Icahn School of Medicine at Mount Sinai, to screen for four additional diseases that are lysosomal storage disorders (LSDs). Four New York City hospitals are participating and approximately 500 infants are being tested weekly in the pilot study.  The newest disorder to be tested is called Hurler syndrome.

Cystic Fibrosis Foundation Funds Collaborative Newborn Screening Project at the Wadsworth Center

The Newborn Screening Program at the Wadsworth Center has been awarded a two-year Cystic Fibrosis Foundation Screening Improvement Program (SIP) grant titled CF-GENES-II: Improving Genetic Counseling Access for Caregivers of Infants with Cystic Fibrosis Newborn Screen-Positive, Inconclusive Diagnosis in New York State.The Wadsworth Center screens every infant born in New York State for cystic fibrosis (CF). Infants with positive screening results are referred to one of the state’s specialty care centers for diagnostic testing, clinical evaluation, treatment, and follow-up.

Wadsworth Center’s Newborn Screening Program Contributes to Educational Event at the University at Albany College of Integrated Health Sciences

On November 14, 2025, representatives from the Wadsworth Center’s Newborn Screening Program joined faculty, a clinician, and students at the University at Albany’s College of Integrated Health Sciences (CIHS) for the College’s first interprofessional education (IPE) event. The session, titled “Interdisciplinary Perspectives on Newborn Screening,” brought together over 50 students from public health, nursing, and social welfare programs to explore how different professions collaborate to support newborn screening and follow-up care.